Program
Time Table
Brief Program
* For the full program, Please find more here. *Japanese only
Symposium
Symposium1Friday, March 6, 2020, 9:00～11:00
Co-sponsored by Kyowa Kirin Co., Ltd.
Recent advances in genomics and genome-engineering in Hematology/Oncology
- Chairs:
- Koichi Akashi
- （Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine）
- Seishi Ogawa
- （Department of Pathology and Tumor Biology, Kyoto University）
Presenters:
Unbiased discovery of therapeutic vulnerabilities and synthetic lethal relationships in AML
- Takahiro Maeda
- （Center for Cellular and Molecular Medicine Kyushu University Hospital）
Gene editing for autologous hematopoietic stem cell therapy
- Daniel E. Bauer
- （Boston Children's Hospital, Dana-Farber Cancer Institute,
Harvard Medical School）
TP53 mutated myeloid malignancies and their treatment strategy
- Yasuhito Nanya
- （Kyoto University, Dep. of Pathology and Tumor Biology）
Genetic determinants of clinical outcome in allogeneic transplantation for myeloid malignancies
- Coleman Lindsley
- （Dana-Farber Cancer Institute）
Symposium2Friday, March 6, 2020, 13:45～15:15
Co-sponsored by Chugai Pharmaceutical Co., Ltd.
Cord Blood Transplantation in Future
- Chairs:
- Satoshi Takahashi
- （Division of Molecular Therapy, Advanced Clinical Research Center, Department of Hematology, The Institute of Medical Scinece, The University of Tokyo）
- Shuichi Taniguchi
- （Department of Hematology, Toranomon Hospital）
Presenters:
Cord Blood in Transplant Medicine: Recent Progress and Future Directions
- John E. Wagner
- （University of Minnesota）
Recent Progress of Cord Blood Transplantation
- Vanderson Geraldo Rocha
- （Hospital das Cinicas da Faculdade de Medicina da Universidade de São Paulo Saint Loius Hospital-France）
The Future Prospects of Cord Blood Transplantation
-A Japanese Perspective-
-A Japanese Perspective-
- Naoyuki Uchida
- （Department of Hematology, Toranomon Hospital）
Symposium3Saturday, March 7, 2020, 9:00～11:00
How to select GVHD prophylaxis in haplo-identical transplantation
- Chairs:
- Toshihiro Miyamoto
- （Hematology & Oncology medicine, Kyushu University Hospital）
- Masayuki Hino
- （Hematology, Graduate School of Medicine, Osaka City University）
Presenters:
GVHD prophylaxis in unmanipulated haplo-HSCT with G-CSF and ATG for leukemia
- Kaiyan Liu
- （Peking University Institute of Hematology, Peking University Peole Hospital）
Unmanipulated haploidentical stem cell transplantation using low-dose ATG and steroid for high-risk diseases
- Kazuhiro Ikegame
- （Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine）
Future strategies for HLA-haploidentical transplantation using high-dose cyclophosphamide
- Hirohisa Nakamae
- （Hematology, Graduate School of Medicine, Osaka City University）
Haploidentical transplantation using alemtuzumab
- Shinichi Kako
- （Division of Hematology, Jichi Medical University Saitama Medical Center）
Symposium4Saturday, March 7, 2020, 14:50～16:00
Management of post-cell therapy cytokine storm
- Chairs:
- Yoshinobu Kanda
- （Division of Hematology, Department of Medicine, Jichi Medical University）
- Naoyuki Uchida
- （Department of Hematology, Toranomon Hospital）
Presenters:
The current status of CAR-T therapy in China and management of CRS
- Xiao-Jun Huang
- （Peking University People’s Hospital, Peking University Institute of Hematology）
Cytokine release syndrome after HLA-haploidentical SCT using posttransplant cyclophosphamide
- Junichi Sugita
- （Department of Hematology, Hokkaido University Hospital）
Pathophysiology and clinical significance of PIR in cord blood transplantation
- Hisashi Yamamoto
- （Department of Hematology, Toranomon Hospital）
JSHCT-KSBMT Joint Symposium Saturday, March 7, 2020, 9:00～10:40
Post-transplant complication
- Chairs:
- Shinichiro Okamoto
- （Division of Hematology, Keio University School of Medecine）
- Hoon Kook
- （Department of Pediatrics, Chonnam National University Hwasun Hospital）
Presenters:
Sinusoidal Obstruction Syndrome / Veno-occlusive disease (SOS/VOD) in Japan
- Kimikazu Yakushijin
- （Medical Oncology and Hematology, Kobe University Hospital）
Korean Experiences of Hepatic SOS/VOD: Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) Criteria
- Jae Ho Yoon
- （Catholic Hematology Hospital and Leukemia research institute, Seoul St. Mary's Hospital）
Human herpesvirus-6B encephalitis after allogeneic HSCT: better understanding the clinical impact, diagnosis, and treatment
- Masao Ogata
- （Department of Hematology, Oita University Hospital）
Cytomegalovirus infection in aspect of prophylaxis and virus specific immunity in pediatric haploidentical hematopoietic cell transplantation
- Hyery Kim
- （Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine）